Number of participants in need of re‐consultation by the end of · patients with sore throat
1 finding from 1 review
Patient initiated re‐consultations for the same illness episode · antibiotic use in acute respiratory infections
Shared decision making showed no clear difference in patient initiated re‐consultations for the same illness episode compared with usual care (moderate certainty).
1 finding from 1 review
Patient satisfaction with consultation · antibiotic use in acute respiratory infections
Shared decision making showed no clear difference in patient satisfaction with the consultation compared with usual care (low certainty).
1 finding from 1 review
Death · patients treated for acute bacterial meningitis
1 finding from 1 review
Death: high‐income countries · patients treated for acute bacterial meningitis
1 finding from 1 review
Death: Low/middle‐income countries · patients treated for acute bacterial meningitis
1 finding from 1 review
Deafness · patients treated for acute bacterial meningitis
1 finding from 1 review
Deafness: high‐income countries · patients treated for acute bacterial meningitis
1 finding from 1 review
Deafness: low‐income countries · patients treated for acute bacterial meningitis
1 finding from 1 review
Death · patients treated for S. pneumoniae meningitis
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Cephalosporins showed no clear difference in resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Clinical cure (bacteriological per protocol analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes clinical cure (bacteriological per protocol analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes relapse (ITT analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Relapse (bacteriological per protocol analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes relapse (bacteriological per protocol analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes adverse events (ITT analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Carbacephem may leads to lower resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
Carbacephem showed no clear difference in resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
Carbacephem showed no clear difference in incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
Carbacephem showed no clear difference in adverse events (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
It is very uncertain whether cephalosporins changes resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (very low certainty).
1 finding from 1 review